Antimicrobial peptides (AMPs) are promising candidates for the development of novel antibiotics， but it is difficult to produce sufficient quantities for preclinical and clinical studies due to their toxicity towards microbial expression hosts. To avoid laborious trial-and-error testing for the identification of suitable expression constructs， we have developed a small-scale expression screening platform based on a combinatorial plasmid library.
Antimicrobial peptides (AMPs) are promising candidates for the development of novel antibiotics， but it is difficult to produce sufficient quantities for preclinical and clinical studies due to their toxicity towards microbial expression hosts. To avoid laborious trial-and-error testing for the identification of suitable expression constructs， we have developed a small-scale expression screening platform based on a combinatorial plasmid library.
